When a traditional mammogram may not be enough in detecting breast cancer, GE Healthcare’s SenoBright HD (CESM) takes a multi-modality approach to personalized care based on the patient. Performed as a follow-up to an inconclusive mammogram or ultrasound, SenoBright HD highlights areas of unusual blood flow pattern providing high specificity to help reduce false-positives and prevent unnecessary exams. Designed to offer patients and clinicians the highest level of confidence possible, the SenoBright HD can provide the information to assist clinicians in their breast cancer diagnosis in less than seven minutes using the same equipment with the same staff in one convenient setting.